Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Kourtney Kardashian indulged in a cheat day, just days after flaunting her incredible bikini body. The reality star, 46, ...

Weight loss also becomes harder as we age; menopause, busy lifestyles and years of yo-yo dieting take their toll, and I've ...

The company, which was formerly Baxter’s kidney care unit, becoming Vantive after being spun out as part of a $3.5bn ...

Wegovy and other GLP-1 obesity and blood sugar control drugs accounted for 17% of pharmacy benefits spending at CBIZ employer ...

Biocon has received approval in India for its generic version of Victoza, marking its first GLP-1 diabetes therapy clearance ...

Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.

Emerging evidence reveals a clinically significant rebound effect following the discontinuation of glucagon-like peptide-1 ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

Doctors have warned users of medicines such as Ozempic Wegovy and Mounjaro about an irreversible potential side effect ...

The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's (NYSE: LLY) Zepbound delivering ...

Regeneron’s trial shows semaglutide combos improve fat loss while preserving muscle in obesity treatment. Read more here.